joe rogan andrew huberman bpc 157 Search 2195 - Andrew Huberman |
Description
Peptides like BPC-157 and Retatrutide are not FDA approved
Amgen is developing MariTide (AMG 133), a GLP-1 receptor and GIPR agonist aimed at treating obesity
they work differently
Do not use product with phase separation or turbidity
